BSE Live
Dec 29, 16:01Prev. Close
3812.85
Open Price
3812.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 29, 15:44Prev. Close
3816.60
Open Price
3801.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 55.46 | 44.05 | 28.48 | 50.48 | 102.99 | |
| Diluted EPS (Rs.) | 55.46 | 44.05 | 28.48 | 50.48 | 102.99 | |
| Cash EPS (Rs.) | 91.30 | 78.25 | 51.17 | 66.39 | 115.60 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 302.59 | 296.34 | 269.23 | 263.16 | 219.06 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 302.59 | 296.34 | 269.23 | 263.16 | 219.06 | |
| Dividend / Share(Rs.) | 32.00 | 17.00 | 14.00 | 14.00 | 35.00 | |
| Revenue from Operations/Share (Rs.) | 364.48 | 340.49 | 251.02 | 271.37 | 321.41 | |
| PBDIT/Share (Rs.) | 127.27 | 117.88 | 73.25 | 84.30 | 173.39 | |
| PBIT/Share (Rs.) | 91.42 | 83.67 | 50.57 | 68.39 | 160.78 | |
| PBT/Share (Rs.) | 65.99 | 55.25 | 33.21 | 56.43 | 138.76 | |
| Net Profit/Share (Rs.) | 55.45 | 44.05 | 28.48 | 50.47 | 102.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 34.91 | 34.62 | 29.18 | 31.06 | 53.94 | |
| PBIT Margin (%) | 25.08 | 24.57 | 20.14 | 25.20 | 50.02 | |
| PBT Margin (%) | 18.10 | 16.22 | 13.23 | 20.79 | 43.17 | |
| Net Profit Margin (%) | 15.21 | 12.93 | 11.34 | 18.59 | 32.04 | |
| Return on Networth / Equity (%) | 18.32 | 14.86 | 10.57 | 19.17 | 47.01 | |
| Return on Capital Employed (%) | 18.20 | 15.84 | 5.45 | 12.38 | 30.12 | |
| Return on Assets (%) | 7.89 | 6.19 | 4.07 | 10.61 | 23.91 | |
| Total Debt/Equity (X) | 0.76 | 0.89 | 1.13 | 0.50 | 0.48 | |
| Asset Turnover Ratio (%) | 51.90 | 47.91 | 35.94 | 57.04 | 74.63 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.13 | 1.21 | 1.22 | 3.07 | 2.09 | |
| Quick Ratio (X) | 0.68 | 0.77 | 0.78 | 2.18 | 1.44 | |
| Inventory Turnover Ratio (X) | 4.09 | 4.24 | 3.27 | 4.45 | 5.61 | |
| Dividend Payout Ratio (NP) (%) | 64.91 | 40.86 | 45.63 | 19.80 | 40.04 | |
| Dividend Payout Ratio (CP) (%) | 39.42 | 23.00 | 25.40 | 15.06 | 35.67 | |
| Earnings Retention Ratio (%) | 35.09 | 59.14 | 54.37 | 80.20 | 59.96 | |
| Cash Earnings Retention Ratio (%) | 60.58 | 77.00 | 74.60 | 84.94 | 64.33 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 36,888.48 | 37,267.78 | 26,214.00 | 28,350.03 | 24,374.98 | |
| EV/Net Operating Revenue (X) | 5.98 | 6.47 | 6.17 | 6.17 | 4.48 | |
| EV/EBITDA (X) | 17.13 | 18.68 | 21.15 | 19.87 | 8.31 | |
| MarketCap/Net Operating Revenue (X) | 5.41 | 5.73 | 4.97 | 5.71 | 4.17 | |
| Retention Ratios (%) | 35.08 | 59.13 | 54.36 | 80.19 | 59.95 | |
| Price/BV (X) | 6.52 | 6.59 | 4.64 | 5.89 | 6.12 | |
| Price/Net Operating Revenue | 5.41 | 5.73 | 4.97 | 5.71 | 4.17 | |
| Earnings Yield | 0.03 | 0.02 | 0.02 | 0.03 | 0.08 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012